Compared with that in the untreated-tumor bearing group, the level of HIF-1α expression in animal glioma tissues treated with borneol and/or TMZ was significantly reduced (Fig. 5A), and the effect of combined therapy was even greater. The gene discussed is HIF1A; the disease is glioma.